vimarsana.com

The World Health Organization (WHO) on Friday listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The vaccine from Janssen is the first to be listed by WHO as a single dose regimen, which should facilitate vaccination logistics in all countries.

Related Keywords

United Kingdom ,Tedros Adhanom Ghebreyesus ,Janssen Johnson ,World Health Organization ,European Medicines Agency ,Strategic Advisory Group On Immunization Experts ,Reuters ,Tedros Adhanom ,Strategic Advisory Group ,Immunization Experts , ,ஒன்றுபட்டது கிஂக்டம் ,ஜான்சன் ஜான்சன் ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,ராய்ட்டர்ஸ் ,நோய்த்தடுப்பு நிபுணர்கள் ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.